Clinical Trial Update: Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN) [Phase 1]

View source ↗

Summary

Update on a Phase 1 trial evaluating local decitabine treatment for HPV-induced vulvar intraepithelial neoplasia grades 2/3 (DelVIN); the study conducted by ViM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: ViMREX GmbH | Conditions: Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3 | Phase 1 | Status: COMPLETED